Danazol increasingly used.
letter
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper analyzes the increasing use of Danazol, a synthetic androgen derivative, highlighting trends and patterns in its prescription and application.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (4)
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex
- Pituitary Gonadotropin Responsiveness with Danazol via openalex
Cited by (8)
- The Treatment of Symptomatic Benign Breast Disease with Danazol 1988
- Danazol treatment of advanced prostate cancer: Clinical and hormonal effects 1986
- Ultrastructural Changes in Endometriotic Tissue During Danazol Treatment 1981
- Review: The Mechanism of Action of Danazol, a Novel Steroid Derivative 1980
- Danazol in the Treatment of Infertility 1980
- Danazol in the Treatment of Mammary Dysplasia 1980
- The Treatment of Benign Breast Disease with Danazol 1980
- Danazol for benign breast disease 1980
Source provenance
- openalex
- last seen: 2026-05-10T10:10:46.048155+00:00
License: CC0
· commercial use OK